Real-World Treatment Patterns and Clinical Outcomes in Canadian Patients with AML Unfit for First-Line Intensive Chemotherapy

Acute myeloid leukemia (AML) is a hematological malignancy that predominantly affects the elderly. Prognosis declines with age. For those who cannot tolerate intensive chemotherapy, historically established treatment options have been hypomethylating agents (HMAs), low dose cytarabine (LDAC), and be...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanford, David, Desjardins, Pierre, Leber, Brian, Paulson, Kristjan, Assouline, Sarit, Lembo, Paola M. C., Fournier, Pierre-André, Leitch, Heather A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600019/
https://www.ncbi.nlm.nih.gov/pubmed/36290812
http://dx.doi.org/10.3390/curroncol29100535

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9600019/
https://www.ncbi.nlm.nih.gov/pubmed/36290812
http://dx.doi.org/10.3390/curroncol29100535

Ejemplares similares